HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Yabe Selected Research

keishi-to

4/2017Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Yabe Research Topics

Disease

6Inflammation (Inflammations)
10/2016 - 10/2004
3Autism Spectrum Disorder
05/2019 - 01/2017
1Autistic Disorder (Autism)
01/2019
1Neurodevelopmental Disorders
04/2017
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2017
1Adenocarcinoma
01/2016
1Necrosis
07/2013
1Retinal Degeneration
11/2008
1Retinitis Pigmentosa (Pigmentary Retinopathy)
11/2008
1Starvation
11/2008
1Blindness (Hysterical Blindness)
11/2008
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2008
1Infarction (Infarctions)
03/2008
1Brain Ischemia (Cerebral Ischemia)
03/2008
1Parkinson Disease (Parkinson's Disease)
11/2005
1Retinal Neovascularization
09/2005
1Brain Injuries (Brain Injury)
09/2005
1Ischemia
09/2005
1Asthma (Bronchial Asthma)
10/2004

Drug/Important Bio-Agent (IBA)

2Dopamine (Intropin)FDA LinkGeneric
05/2019 - 11/2005
2kamisyoyo sanIBA
05/2019 - 01/2019
2Pregnanolone (Allopregnanolone)IBA
01/2019 - 01/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2016 - 03/2010
2LipopolysaccharidesIBA
10/2016 - 01/2016
2Messenger RNA (mRNA)IBA
10/2014 - 07/2013
1Yi-Gan SanIBA
04/2017
1keishi-toIBA
04/2017
1Pharmaceutical PreparationsIBA
04/2017
1Methylphenidate (Ritalin)FDA LinkGeneric
04/2017
1dibenzocyclooctadiene lignanIBA
10/2016
1schizandrin BIBA
10/2016
1EndotoxinsIBA
10/2016
1InterleukinsIBA
10/2016
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2016
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2016
1kamikihi-to (KKT)IBA
01/2016
1genipinIBA
10/2014
1Fibroblast Growth Factor 7FDA Link
07/2013
1Methotrexate (Mexate)FDA LinkGeneric
07/2013
1Tumor Biomarkers (Tumor Markers)IBA
07/2013
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
03/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
03/2010
1pigment epithelium-derived factorIBA
11/2008
1Retinaldehyde (Retinal)IBA
11/2008
1Apoptosis Inducing FactorIBA
11/2008
1CaspasesIBA
11/2008
1Neuroprotective AgentsIBA
08/2008
1Plasminogen Activator Inhibitor 1IBA
03/2008
1Glutamic Acid (Glutamate)FDA Link
03/2008
1Endothelin B ReceptorIBA
03/2008
1Oxidopamine (6 Hydroxydopamine)IBA
11/2005
1ChemokinesIBA
09/2005
1sho-seiryu-toIBA
10/2004
1Anti-Allergic Agents (Antiallergic Agents)IBA
10/2004
1OvalbuminIBA
10/2004

Therapy/Procedure

2Kampo Medicine (Kampo)
04/2017 - 10/2004
1Oral Administration
07/2013
1Therapeutics
11/2005